Baricitinib for the Treatment of Moderate-To-Severe Alopecia Areata

    January 2025 in “ Balkan Medical Journal ”
    Güllü Gencebay, Anıl Gülsel Bahalı, Didem Dizman, Melisa Özay, Özlem Su
    Image of study
    TLDR Baricitinib helps regrow hair in severe alopecia areata and is safe, but more research is needed.
    This study assessed the effectiveness of baricitinib, a JAK inhibitor, in treating 14 patients with severe alopecia areata. Over 3 to 12 months, 57% of patients experienced at least a 50% improvement in hair regrowth, with 21% achieving complete regrowth. Adverse events were mild. The study concludes that baricitinib is effective and well-tolerated for treating refractory alopecia areata, but larger trials are necessary to confirm these results.
    Discuss this study in the Community →

    Research cited in this study

    5 / 5 results

    Related Community Posts Join

    6 / 11 results

      community What else is good. Besides the big 3.

      in Chat  34 upvotes 3 months ago
      Key treatments for hair preservation include minoxidil, finasteride/dutasteride, and microneedling, with additional options like specific shampoos, oils, biotin, zinc, tretinoin, clascoterone, and low-level laser therapy. Maintaining a healthy lifestyle, reducing stress, and addressing nutrient deficiencies can also support hair health.

      community I am a dermatologist with a clinical interest in alopecia. AMA

      in Will treatment work for me? 2 years ago
      In this conversation, 4990 discussed various treatments for hair loss, including oral minoxidil, PRP, transplan, Jak inhibitors, Dutasteride, Finasteride, Olumiant, Ketoconazole, RU58841, microneedling, baricitinib, and CCCA. They recommended scalp biopsies in unclear cases of DUPA, twice weekly to twice daily shampooing for topical minoxidil users, and two sessions spaced one month apart with follow up at month three to determine the effectiveness of PRP treatment.

      community Should I get transplant #4 or just shave my head?

      in Transplants  172 upvotes 5 months ago
      A 36-year-old considering a fourth hair transplant is advised to either shave his head or use a hair system due to poor results from previous transplants and late medication use. He plans to consult top surgeons and adjust his current treatments, including finasteride and minoxidil.
      [object Object]

      community Olumiant active ingredient Baricitinib

      in Research/Science  1 upvotes 2 years ago
      The conversation is about someone inquiring if anyone has tried Olumiant or its active ingredient, Baricitinib, for hair loss, mentioning the cost and that they have ordered Baricitinib.

    Related Research

    1 / 1 results